The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
It's sort of like the leap from, I can't focus very well, to Ritalin, right, without a real diagnosis of ADHD to, oh well, maybe some things like Alpha-GPC low doses of nicotine, right? But I agree entirely. I mean, the sourcing is important. The dosages are worked out empirically on an individual basis. And there aren't randomized control trials. There just aren't.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.